Late-Breaking Clinical Trials

Submission Deadline: Tuesday, January 26, 2021, 1:00 p.m. ET.

Submission Instructions

Policies and Procedures

The ACC is now accepting submissions of Late-Breaking Clinical Trials. Join us for ACC.21, in Atlanta or virtually, for cutting-edge science.

Submit Late-Breaking Clinical Trials in any of the following categories:

  • Major Study
  • Smaller Study/Randomized Clinical Trial
  • Multi-center Observational Study or Registry
  • Secondary Analysis of Major Clinical Trial
  • Other

Accepted Late-Breaking Clinical Trial submissions will be presented in the ACC.21 Main Tent during one of five LBCT sessions and streamed live via ACC.21 Virtual. Three LBCT sessions will be co-sponsored by the Journal of the American College of Cardiology (JACC), the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM). Each accepted submission will be considered for JACC Rapid Review and publication in JACC, JAMA and NEJM. In addition, each LBCT session will be followed by a press conference with top media outlets.

ACC Logo
ACC.21 on Social Media:
2020 American College of Cardiology Foundation. Visit
Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Cookie Policy Contact Us